MedPath

University of Alberta

University of Alberta logo
🇨🇦Canada
Ownership
Private
Established
1908-01-01
Employees
10K
Market Cap
-
Website
http://www.ualberta.ca

Non-Steroidal or Opioid Analgesia Use for Children With Musculoskeletal Injuries

First Posted Date
2018-12-07
Last Posted Date
2023-04-10
Lead Sponsor
University of Alberta
Target Recruit Count
710
Registration Number
NCT03767933
Locations
🇨🇦

Children's Hospital of Winnipeg, Winnipeg, Manitoba, Canada

🇨🇦

Stollery Children's Hospital Emergency Department, Edmonton, Alberta, Canada

🇨🇦

Alberta Children's Hospital, Calgary, Alberta, Canada

and more 3 locations

Fecal Microbiota Transplant (FMT) Plus Fidaxomicin for Severe or Fulminant Clostridium Difficile Infection

Phase 2
Terminated
Conditions
Clostridium Difficile
Interventions
Biological: fecal microbiota transplantation (FMT)
First Posted Date
2018-11-30
Last Posted Date
2022-12-13
Lead Sponsor
University of Alberta
Target Recruit Count
4
Registration Number
NCT03760484
Locations
🇨🇦

University of Alberta Hospital, Edmonton, Alberta, Canada

Influence of Coffee Consumption on BIA-derived Body Composition Parameters

Not Applicable
Completed
Conditions
Healthy
Interventions
Other: Instant Coffee
First Posted Date
2018-11-19
Last Posted Date
2019-07-24
Lead Sponsor
University of Alberta
Target Recruit Count
26
Registration Number
NCT03745508
Locations
🇨🇦

University of Alberta, Edmonton, Alberta, Canada

Group CBT and Exercise in Management of Depression

Not Applicable
Terminated
Conditions
Major Depressive Disorder
Interventions
Behavioral: Group exercise
Behavioral: Group CBT
First Posted Date
2018-11-06
Last Posted Date
2020-11-12
Lead Sponsor
University of Alberta
Target Recruit Count
70
Registration Number
NCT03731728
Locations
🇨🇦

Royal Alexander Hospital, Edmonton, Alberta, Canada

FMT and Fiber in Patients With Metabolic Syndrome

Phase 2
Completed
Conditions
Metabolic Syndrome
Obesity
Interventions
Combination Product: Fecal Microbial Transplant
Dietary Supplement: Fiber
Dietary Supplement: Cellulose
First Posted Date
2018-11-01
Last Posted Date
2020-05-05
Lead Sponsor
University of Alberta
Target Recruit Count
68
Registration Number
NCT03727321
Locations
🇨🇦

University of Alberta Hospital, Edmonton, Alberta, Canada

🇨🇦

Royal Alexandra Hospital, Edmonton, Alberta, Canada

Effectiveness of Ropinirole and Gabapentin for the Treatment of RLS in Patients on Maintenance HD

Phase 2
Terminated
Conditions
Restless Legs Syndrome
End Stage Renal Disease
Interventions
First Posted Date
2018-10-17
Last Posted Date
2022-07-12
Lead Sponsor
University of Alberta
Target Recruit Count
3
Registration Number
NCT03708237
Locations
🇨🇦

Edmonton General Continuing Care Centre, Edmonton, Canada

🇨🇦

Royal Alexandra Hospital, Edmonton, Canada

🇨🇦

Grey Nuns Community Hospital, Edmonton, Canada

and more 1 locations

The Hilo Pilot -Trial to Assess Feasibility

Not Applicable
Completed
Conditions
Respiratory Distress Syndrome
Premature Infant
Interventions
Procedure: 60% group
Procedure: 30% group
First Posted Date
2018-10-16
Last Posted Date
2021-09-05
Lead Sponsor
University of Alberta
Target Recruit Count
34
Registration Number
NCT03706586
Locations
🇨🇦

Royal Alexandra Hospital, Edmonton, Alberta, Canada

Initiation of Resuscitation While Attached to the Cord With Congenital Heart Disease

Not Applicable
Withdrawn
Conditions
Congenital Heart Defect
TGA - Transposition of Great Arteries
Hypoplastic Left Heart Syndrome
Hypoplastic Right Heart Syndrome
Congential Malformations of Aortic Valve
Congential Absence of Heart Structure
Congenital Malformation of Heart, Unspecified
Congential Malformations of Great Arteries
Interventions
Procedure: Initiation of Resuscitation While Attached to the Cord
First Posted Date
2018-10-01
Last Posted Date
2020-03-24
Lead Sponsor
University of Alberta
Registration Number
NCT03690245
Locations
🇨🇦

Royal Alexandra Hospital, Edmonton, Alberta, Canada

Vascular Implications of a Naturally Occurring Asthma Exacerbation

Terminated
Conditions
Inflammation
Asthma
Cardiovascular Risk Factor
Interventions
Other: Observational - No intervention
First Posted Date
2018-09-20
Last Posted Date
2024-07-05
Lead Sponsor
University of Alberta
Target Recruit Count
3
Registration Number
NCT03679299
Locations
🇨🇦

University of Alberta Hospital Emergency Department, Edmonton, Alberta, Canada

🇨🇦

Desi Fuhr, Edmonton, Alberta, Canada

The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in COPD

Phase 1
Completed
Conditions
Dyspnea
Interventions
Drug: Placebo
First Posted Date
2018-09-20
Last Posted Date
2024-01-11
Lead Sponsor
University of Alberta
Target Recruit Count
140
Registration Number
NCT03679312
Locations
🇨🇦

Clinical Sciences Building, Edmonton, Alberta, Canada

© Copyright 2025. All Rights Reserved by MedPath